Elevated insulin, norepinephrine, and neuropeptide Y in hypertension.
about
Inhibitory effects of angiotensin-(1-7) on the nerve stimulation-induced release of norepinephrine and neuropeptide Y from the mesenteric arterial bed.Changes in plasma catecholamine and neuropeptide Y levels after sympathetic activation in dogs.Elevated levels of neuropeptide Y in preeclampsia: A pilot study implicating a role for stress in pathogenesis of the disease.Is norepinephrine an etiological factor in some types of cancer?Pathogenesis of the essential hypertensions.Cardiovasoactive peptides in hemodialysis patients: diagnostic tools and predictors of outcome: a review of present knowledge and future directions.Is elevated noradrenaline an aetiological factor in a number of diseases?Noradrenaline transmission reducing drugs may protect against a broad range of diseases.Increased blood pressure responses in neuropeptide Y transgenic rats.Appetite regulatory peptides in Indian Antarctic expeditioners.Nitric oxide decreases the biological activity of norepinephrine resulting in altered vascular tone in the rat mesenteric arterial bed.Clonidine but not propranolol decreases plasma neuropeptide Y (NPY) levels.Neuropeptide Y gene functional polymorphism influences susceptibility to hypertension in Indian population.A population study of plasma neuropeptide Y: correlations with components of the metabolic syndrome.Ambulatory 24-hour blood pressure and peptide balance in hemodialysis patients.Ventricular ectopic activity, left ventricular mass, hyperinsulinemia, and intracellular magnesium in normotensive patients with obesity.Plasma neuropeptide Y and catecholamines in women and men with essential hypertension.Neuropeptide Y in human hand veins: Pharmacologic characterization and interaction with cyclic guanosine monophosphate-dependent venodilators in vivo*
P2860
Q33655956-AC8FF5DC-6D58-4D70-808F-8C81B637D21FQ35872380-125DC736-883F-4798-A8D5-EA8B375CD7D3Q36586387-8C0F9BB9-8C50-4CF8-B30A-3C0ABDD29F18Q37323747-C1F19AEB-2F4F-44D8-BECD-9F9DEB75371BQ37358964-C6FA5940-F2AD-4558-96EE-102CAC53E724Q37451756-86DAA5F0-74BB-4F89-A35E-E9FED662D33FQ37594137-355C5F9E-1253-49F4-B34D-3E5310060EE8Q38255794-38DDFF0A-9D3D-4607-9BFF-289CF20662FAQ43670772-EB7A8B4E-8FB7-4268-B0F6-8BB9678D48D9Q43829171-0A87F061-1FA3-45EF-86CD-C6614FFA6D05Q44698708-28976D6F-7E6B-485A-B6CD-6EF71A6C8894Q45337708-5E363438-70C7-42A7-9A39-DCF77B599257Q45344919-453D7659-1B25-4AE8-956D-77461C9094CFQ50983898-8795C728-A6DD-4C0C-89B1-B6B56591AEFAQ51039816-3CB8E873-C1A2-4162-B910-6EA544CAE238Q51557930-BA315F6C-AF37-4248-AB33-1CD12F9730CAQ52342564-1358B03B-FC63-4670-ABC3-8B89FCF6019BQ56832856-09FADC47-8A43-466A-B5FB-A464DA8FF4BB
P2860
Elevated insulin, norepinephrine, and neuropeptide Y in hypertension.
description
1990 nî lūn-bûn
@nan
1990年の論文
@ja
1990年学术文章
@wuu
1990年学术文章
@zh
1990年学术文章
@zh-cn
1990年学术文章
@zh-hans
1990年学术文章
@zh-my
1990年学术文章
@zh-sg
1990年學術文章
@yue
1990年學術文章
@zh-hant
name
Elevated insulin, norepinephrine, and neuropeptide Y in hypertension.
@en
Elevated insulin, norepinephrine, and neuropeptide Y in hypertension.
@nl
type
label
Elevated insulin, norepinephrine, and neuropeptide Y in hypertension.
@en
Elevated insulin, norepinephrine, and neuropeptide Y in hypertension.
@nl
prefLabel
Elevated insulin, norepinephrine, and neuropeptide Y in hypertension.
@en
Elevated insulin, norepinephrine, and neuropeptide Y in hypertension.
@nl
P2093
P356
P1476
Elevated insulin, norepinephrine, and neuropeptide Y in hypertension.
@en
P2093
P304
P356
10.1093/AJH/3.11.823
P577
1990-11-01T00:00:00Z